Treatment of hypo- and hyperthyroidism during pregnancy;Therapie der Hypo- und Hyperthyreose in der Schwangerschaft

Acta Medica Austriaca

Volumn 24, Issue 4, 1997, Pages 157-158

  Lind, P ^a  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

Hyperthyroidism; Hypothyroidism; Pregnancy; Therapy

Indexed keywords

ANTITHYROID AGENT; PROPYLTHIOURACIL; THIAMAZOLE; THYROXINE;

CONGENITAL MALFORMATION; DOSE RESPONSE; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK FACTOR; THYROID FUNCTION TEST;

ABNORMALITIES, DRUG-INDUCED; ANTITHYROID AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INFANT, NEWBORN; METHIMAZOLE; PREGNANCY; PREGNANCY COMPLICATIONS; PROPYLTHIOURACIL; RISK FACTORS; THYROID FUNCTION TESTS; THYROXINE;

EID: 0031297761     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Amino N, Miyai K, Yamamoto T, Kuro R, Tanaka F, Tanizawa O, Kumahara Y: Transient recurrence of hypcrthyroidism after delivery in Graves' disease. J Clin Endocrinol Metab 1977;44:130-136.
2. Bachrach LK, Burrow GN: Aplasia cutis congenita and methimazole. Can Med Ass J 1984;130:1264-1266.
3. Burrow GN: Antithyroid drug treatment in the thyrotoxic pregnant women. In C Beckers, D Reinwein (eds): Thyroid and pregnancy. Stuttgart-New York, Schattauer, 1991, pp 105-113.
4. Burrow GN: Thyroid function and hyperfunction during gestation. Endocrine Rev 1993;14:194-202.
5. Burrow GN, Bartsocas C, Klatskin EH, Grunt JA: Children exposed in utero to propylthiouracil: subsequent intellectual and physical development. Am J Dis Child 1968;116:161-166.